increasing prevalence of brain cancer is driving the Brain Tumor Diagnostics Market

Latest News:- Brain Tumor Diagnostics Market: Imaging test is expected to lead the Type segment during 2024-2028

Technavio analyzes that the Brain Tumor Diagnostics Market is expected to grow at a CAGR of 3.4% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 152.9 million.There are various factors that contribute to the growth of the market. The Brain Tumor Diagnostics Market is experiencing significant growth due to the increasing prevalence of brain cancer worldwide. Brain cancer is a serious condition with a rising incidence rate, particularly in developing countries. Early and accurate diagnosis is crucial for effective treatment and improving patient outcomes. Advanced diagnostic tools and techniques, such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and biomarker testing, are driving market expansion in this sector. The integration of artificial intelligence and machine learning technologies in brain tumor diagnosis is also expected to revolutionize the industry. The market is expected to witness robust growth in the coming years, as the demand for early and accurate brain tumor diagnosis continues to increase.

The Brain Tumor Diagnostics Market is witnessing significant growth due to the increasing prevalence of brain tumors and associated cancers. Gliomas are a major type of brain tumor, driving the demand for advanced diagnostic procedures. Hospitals are the largest end-users of brain tumor diagnostic solutions, given the high patient volume. Technological advancements in diagnostic procedures, such as chemotherapy and radiotherapy, are improving patient survival rates. The Imaging Test segment is experiencing moderate growth, driven by the rising adoption of medical imaging in diagnosing brain tumors. Product launches and mergers & acquisitions are fueling the demand for medical imaging technology. However, conventional imaging equipment faces challenges due to its moderate image resolution, low processing speed, and high radiation doses, necessitating the shift towards digital medical imaging systems. 

Know which region is leading the market growth by requesting a sample report

Brain Tumor Diagnostics Market Segmentation

• Type
  • Imaging test
  • Biopsy
  • Molecular testing
  • Others
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

• Amgen Inc.
• AstraZeneca Plc
• Biocept Inc.
• Canon Inc.
• FUJIFILM Holdings Corporation
• GE Healthcare Technologies Inc.
• Hitachi Ltd.
• Hologic Inc.
• Koninklijke Philips N.V.
• MDXHEALTH SA
• Merck and Co. Inc.
• NantOmics
• Neusoft Medical Systems Co. Ltd.
• Pfizer Inc.
• Shimadzu Corp.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

Brain tumors, a type of neurological disorder and a form of cancer, require advanced diagnostic solutions for early detection. Malignant glioblastomas, a common and aggressive brain cancer, can be diagnosed through various diagnostic tools such as imaging technologies like MRI and magnetic resonance imaging, diagnostic procedures including biopsies and blood tests, and neurological evaluations. Non-invasive techniques like genetic testing are also utilized. Early detection increases patient survival rates, enabling effective treatment regimens using chemotherapy and radiotherapy. Smoking is a risk factor for brain cancer, and screening programs can help identify those at high risk. Imaging investigations, diagnostic procedures, and medical tools play crucial roles in the diagnosis and management of brain tumors.

Market Research Overview

The Brain Tumor Diagnostics Market is a significant segment of the global Healthcare Equipment Market, encompassing companies and solutions dedicated to the research, development, and provision of advanced diagnostic tools for neurological disorders, specifically brain cancer. These diagnostic solutions include non-invasive techniques and screening programs, which are crucial for early detection and effective treatment. Technavio, a leading market research firm, calculates the size of the Healthcare Equipment Market by aggregating the revenues of manufacturers of various diagnostic equipment and devices. This industry comprises devices, including advanced, differentiated, and clinically tested solutions, used for the diagnosis, monitoring, and treatment of various diseases, including brain tumors.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

• Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.


• Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.


• High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/